Home/Filings/4/0001140361-24-047758
4//SEC Filing

ZERBE ROBERT L MD 4

Accession 0001140361-24-047758

CIK 0000887359other

Filed

Nov 24, 7:00 PM ET

Accepted

Nov 25, 4:05 PM ET

Size

8.1 KB

Accession

0001140361-24-047758

Insider Transaction Report

Form 4
Period: 2024-11-22
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-11-22+2,50010,000 total
    Exercise: $13.05Exp: 2028-05-02Common Stock (2,500 underlying)
  • Exercise/Conversion

    Common Stock

    2024-11-22$13.05/sh+2,500$32,62529,095 total
  • Sale

    Common Stock

    2024-11-22$60.00/sh2,500$150,00026,595 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2024.
  • [F2]These options, representing the right to purchase 17,500 shares, were originally granted on May 2, 2018, becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from June 2, 2018 through May 2, 2019.

Issuer

Vericel Corp

CIK 0000887359

Entity typeother

Related Parties

1
  • filerCIK 0001220363

Filing Metadata

Form type
4
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 4:05 PM ET
Size
8.1 KB